Improved Design And Production Of Bispecific Therapeutics

As the market for bispecific antibody therapeutics continues to soar, novel solutions are required to overcome challenges in producing these next-generation molecules. In this presentation, our expert demonstrates how bYlok^® uses a close-to-nature design solution to deliver high accurate heavy-light chain pairing efficiencies and improved manufacturability, with no observed effect on immunogenicity.